ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of VEGF-Antisense Oligonucleotide in Combination With Pemetrexed and Cisplatin for the Treatment of Advanced Malignant Mesothelioma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00668499
Recruitment Status : Withdrawn (Sponsor withdrew support)
First Posted : April 29, 2008
Last Update Posted : May 21, 2014
Sponsor:
Collaborator:
Sponsor Name Pending
Information provided by:
University of Southern California

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : April 2011
  Estimated Study Completion Date : April 2011